Cart
sales@molnova.com
N-Acetyl-L-arginine dihydrate
CAS No. 210545-23-6
N-Acetyl-L-arginine dihydrate( N-Ac-L-arg-OH )
Catalog No. M20060 CAS No. 210545-23-6
N-alpha-Acetylarginine is one of the guanidino compounds found elevated in the serum of a hemodialyzed renal insufficient (uremic) pediatric population.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 45 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Acetyl-L-arginine dihydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-alpha-Acetylarginine is one of the guanidino compounds found elevated in the serum of a hemodialyzed renal insufficient (uremic) pediatric population.
-
DescriptionN-alpha-Acetylarginine is one of the guanidino compounds found elevated in the serum of a hemodialyzed renal insufficient (uremic) pediatric population.
-
In Vitro——
-
In Vivo——
-
SynonymsN-Ac-L-arg-OH
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number210545-23-6
-
Formula Weight252.27
-
Molecular FormulaC8H20N4O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO.O.CC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.De Deyn PP et al. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations. Nephron. 1995;69(4):411-7.
molnova catalog
related products
-
N-Methylcalycinine
N-Methylcalycinine exhibits potent AChE inhibitory activity.
-
Propidium Iodide
Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients.
-
IACS-52825
IACS-52825 is a selective and potent dual leucine zipper kinase (DLK) inhibitor that reverses para-mechanical aberrant pain in a CIPN mouse model for the study of neurological disorders.
